ScitoVation Overview

  • Founded
  • 2015
  • Status
  • Private
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 1

ScitoVation General Information


Provider of technical expertise and technology intended to understand how chemical compounds affect human health. The company specializes in investigating complex issues such as mode of action of a chemical, extrapolation of animal to human exposure and the use of genetic expression and sequencing data to ascertain toxicity, thereby helping clients develop safer and more effective pharmaceuticals, food ingredients, agricultural chemicals, commodity chemicals and consumer products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • 100 Capitola Drive
  • Suite 106
  • Durham, NC 27713
  • United States
+1 (919) 000-0000

ScitoVation Timeline

Financing RoundFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ScitoVation Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - PPP 07-Apr-2020 000 Completed
2. Angel (individual) 12-Feb-2020 0000 000 Completed Generating Revenue
1. Grant 01-Jan-2017 $147K Completed Startup
To view ScitoVation’s complete valuation and funding history, request access »

ScitoVation Executive Team (1)

Name Title Board Seat Contact Info
Jean Orelien Chief Executive Officer & President
To view ScitoVation’s complete executive team members history, request access »

ScitoVation Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view ScitoVation’s complete investors history, request access »